Fewer Hospital Visits | Rhabdomyosarcoma | Triple-Negative Breast Cancer, Cancer Information Highlights, 08/17/2022

National Cancer Institute sent this bulletin at 08/17/2022 11:21 AM EDT
National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share
Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
Aided by Community Health Workers, People with Advanced Cancer Have Fewer Hospital Visits
  For people with advanced cancer, regular home visits and calls from community health workers increased use of palliative care and improved quality of life, among other benefits, a new study found.
A Potential Treatment Approach for Rhabdomyosarcoma
KDM4B paired with PAX3-FOXO1 opens DNA, turns genes on, causing tumors to grow. When KDM4B is blocked, DNA closes, genes turn off, causing tumors to shrink.   The protein that drives the growth and survival of some rhabdomyosarcoma tumors relies on the KDM4B enzyme, researchers found. Treating mice with a KDM4B-blocking drug and chemotherapy got rid of nearly all rhabdomyosarcoma tumors with the protein.
Immunotherapy Improves Survival in Advanced Triple-Negative Breast Cancer

Learn more about a recent study that suggests that adding the immunotherapy drug pembrolizumab (Keytruda) to chemotherapy can help some people with advanced triple-negative breast cancer live longer than if they received chemotherapy alone.
Tumor Grade

This updated page defines tumor grade, how it is determined, and how it is used to plan cancer treatment.
PDQ Updates
Treatment for Childhood Central Nervous System Germ Cell Tumors

Germ cell tumors that form in the brain or spinal cord are called central nervous system (CNS) germ cell tumors. Learn about the signs, tests to diagnose, and treatment of these tumors in children.
FDA Approvals
Fam-Trastuzumab Deruxtecan-nxki

We’ve updated our fam-trastuzumab deruxtecan-nxki (Enhertu) drug summary to include a recent Food and Drug Administration approval. This drug is now approved to treat adults with previously treated non-small cell lung cancer that has a certain change in the HER2 gene and that cannot be removed by surgery or has spread to other parts of the body.
 
Also of Interest
Support for Caregivers

Being a caregiver can be stressful. Learn tips for how to care for yourself while caring for others.
NCI Dictionary of Cancer Terms

NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine. New terms and term revisions are reviewed by a multidisciplinary panel and added to the dictionary on an ongoing basis.
Contact Us for Help

Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.